hims semaglutide shortage GLP-1 shortages holding back your weight loss goals? Answer 3 simple questions, update the Supply Tracker and we’ll keep the FDA informed on current access. Help change the future of weight loss Novo is suing Hims &

This abundance makes us eat as much as we can get our hands on, which causes us to save up for a rainy day that doesnt come in modern America

The FDA has acknowledged the reports but has not issued an official warning about Ozempic despite the growing number of patients complaining of gastroparesis and eye conditions

Luckily, these discomforts often subside after the first few weeks

Following the initial top-line readout in August which showed a statistically significant, 20% relative risk reduction in MACE-3 cardiovascular events the veil has finally been lifted from the landmark SELECT cardiovascular outcomes trial

Consistency in both timing and accuracy matters greatly